ArticleCancer biology & therapy2014

Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin.

Irina G Popovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.